THC Farmaceuticals, Inc. (CBDG) Research

THC Farmaceuticals, Inc. specializes in the ownership and operation of independent (non-bank) automated teller machines (ATMs), strategically placing them within third-party retail and commercial establishments. These cash-dispensing units are typically situated in bustling commercial spaces such as hotels, stores, and bowling alleys, aiming for high customer footfall areas that often serve small and medium-sized enterprises. By mid-2015 (June 30), the company reported a network of eight public-access ATMs concentrated in Utah's Wasatch Front region. Founded in 2008 and based in Scottsdale, Arizona, the company adopted its current name, THC Farmaceuticals, Inc., in February 2015, having previously operated as City Media, Inc. THC Farmaceuticals, Inc. functions as a subsidiary of Weed Growth Fund, Inc.

Market snapshot

Symbol
CBDG
Price
$0.01
Day change
0.00%
Market cap
$199.4K
P/E ratio
-19.19x
52-week range
0.0022-0.093
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • ChitogenX Inc. (CHNXF)
  • DH Enchantment Inc. (ENMI)
  • Innovation Pharmaceuticals Inc. (IPIX)
  • Pathfinder Cell Therapy, Inc. (PFND)
  • Actavia Life Sciences, Inc. (RASP)
  • Regen BioPharma, Inc. (RGBP)
  • RespireRx Pharmaceuticals Inc. (RSPI)
  • Sibannac, Inc. (SNNC)

Open THC Farmaceuticals, Inc. (CBDG) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.